- Home
- HSON vs COEP Comparison
HSON vs COEP Comparison
Compare HSON & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSON
- COEP
- Stock Information
- Founded
- HSON 1999
- COEP 2017
- Country
- HSON United States
- COEP United States
- Employees
- HSON N/A
- COEP N/A
- Industry
- HSON Professional Services
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HSON Consumer Discretionary
- COEP Health Care
- Exchange
- HSON Nasdaq
- COEP Nasdaq
- Market Cap
- HSON 23.1M
- COEP 27.4M
- IPO Year
- HSON N/A
- COEP N/A
- Fundamental
- Price
- HSON $9.01
- COEP $10.66
- Analyst Decision
- HSON
- COEP
- Analyst Count
- HSON 0
- COEP 0
- Target Price
- HSON N/A
- COEP N/A
- AVG Volume (30 Days)
- HSON 17.3K
- COEP 46.3K
- Earning Date
- HSON 08-07-2025
- COEP 08-15-2025
- Dividend Yield
- HSON N/A
- COEP N/A
- EPS Growth
- HSON N/A
- COEP N/A
- EPS
- HSON N/A
- COEP N/A
- Revenue
- HSON $138,031,000.00
- COEP $62,874.00
- Revenue This Year
- HSON $0.80
- COEP N/A
- Revenue Next Year
- HSON $8.09
- COEP N/A
- P/E Ratio
- HSON N/A
- COEP N/A
- Revenue Growth
- HSON N/A
- COEP N/A
- 52 Week Low
- HSON $8.26
- COEP $2.31
- 52 Week High
- HSON $18.48
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- HSON 55.45
- COEP 65.93
- Support Level
- HSON $8.26
- COEP $7.25
- Resistance Level
- HSON $8.79
- COEP $11.70
- Average True Range (ATR)
- HSON 0.27
- COEP 0.67
- MACD
- HSON 0.06
- COEP 0.35
- Stochastic Oscillator
- HSON 93.10
- COEP 76.81
About HSON Hudson Global Inc.
Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.